MediFind
Condition

Transverse Myelitis

Latest Research

Latest Advance
Study
  • Condition: Central Nervous System Demyelinating Diseases During the Coronavirus Disease 2019 Pandemic
  • Journal: Arquivos de neuro-psiquiatria
  • Treatment Used: Management Strategies
  • Published —
This article discusses management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic.
Latest Advance
Study
  • Condition: Encephalomyeloneuritis and Arthritis
  • Journal: Neurology(R) neuroimmunology & neuroinflammation
  • Treatment Used: Anti-PD-L1 Inhibitors
  • Number of Patients: 1
  • Published —
This case report describes a patient with encephalomyeloneuritis and arthritis that was treated using anti-PD-L1 inhibitors such as nivolumab and ipilimumab.
Latest Advance
Study
  • Condition: Pneumocystis jirovecii Pneumonia
  • Journal: The Tohoku journal of experimental medicine
  • Treatment Used: Veno-Venous Extracorporeal Membrane Oxygenation
  • Number of Patients: 1
  • Published —
The study reported a case of pneumocystis jirovecii pneumonia treated with veno-venous extracorporeal membrane oxygenation.
Latest Advance
Study
  • Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD) with Persistent Nausea and Repeated Syncope
  • Journal: Rinsho shinkeigaku = Clinical neurology
  • Treatment Used: Steroid Pulse Therapy (Methylprednisolone at 1,000?mg/day for 3 Days)
  • Number of Patients: 1
  • Published —
This case report discusses a 22-year-old woman diagnosed with neuromyelitis optica spectrum disorder (NMOSD) treated with steroid pulse therapy (methylprednisolone at 1,000?mg/day for three days) twice.
Latest Advance
Study
  • Condition: Neuromyelitis Optica Spectrum Disorder
  • Journal: The New England journal of medicine
  • Treatment Used: Satralizumab
  • Number of Patients: 83
  • Published —
The study researched using Satralizumab to treat neuromyelitis optica spectrum disorder.
Latest Advance
Study
  • Condition: Patients with Neuromyelitis Optica Spectrum Disorders (NMOSD)
  • Journal: Multiple sclerosis and related disorders
  • Treatment Used: Different Rituximab (RTX) Therapeutic Strategies
  • Number of Patients: 131
  • Published —
This study evaluated disease activity according to rituximab (RTX) induction and maintenance regimens in a multicenter real-life dataset of patients with neuromyelitis optica spectrum disorders (NMOSD).
Latest Advance
Study
  • Condition: Neuromyelitis Optica
  • Journal: Neurology
  • Treatment Used: Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation
  • Number of Patients: 13
  • Published —
This study tested the safety and efficacy of using an autologous nonmyeloablative hematopoietic stem cell transplantation to treat patients with neuromyelitis optica.
Latest Advance
Study
  • Condition: Immune-Mediated Disorders
  • Journal: Frontiers in immunology
  • Treatment Used: Rituximab
  • Published —
This study investigated the safety and efficacy of using rituximab to treat various immune-mediated disorders.
Latest Advance
Study
  • Condition: Neuromyelitis Optica Spectrum Disorder
  • Journal: Lancet (London, England)
  • Treatment Used: Inebilizumab
  • Number of Patients: 230
  • Published —
This study tested the safety and efficacy of using inebilizumab to treat patients with neuromyelitis optica spectrum disorder.
Latest Advance
Study
  • Condition: Chronic Spinal Cord Injury
  • Journal: The American journal of case reports
  • Treatment Used: transplantation of bone marrow derived mesenchymal stem cells
  • Number of Patients: 1
  • Published —
The purpose of the study was to evaluate the motoric recovery in a chronic spinal cord injury patient treated with bone marrow derived mesenchymal stem cell transplantation.
Latest Advance
Study
  • Condition: Transverse myelitis (TM) chronic pain
  • Journal: A&A practice
  • Treatment Used: Spinal cord stimulation (SCS)
  • Number of Patients: 1
  • Published —
This study presented the case of a 37 year old man with chronic pain associated to Transverse myelitis (TM) who underwent spinal cord stimulation (SCS).
Latest Advance
Study
  • Condition: Preventive Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD)
  • Journal: Multiple sclerosis and related disorders
  • Treatment Used: Immunosuppressants and Monoclonal Antibodies
  • Number of Patients: 631
  • Published —
This study compared and ranked the effectiveness and tolerability of all preventive therapies for neuromyelitis optica spectrum disorders (NMOSD).